fda declares semaglutide shortage over drug shortages injection status resolved 2025 of Novo Nordisk's Wegovy, Ozempic Ozempic's patent problem: how Novo – Semigluti Shortage | TikTok

GLP-1 weight loss injections are once-weekly prescription medications, semaglutide and tirzepatide, that mimic gut hormones to reduce appetite, slow gastric emptying, improve insulin response, and shift fat metabolism

Abstract Failure to reperfuse the coronary microvasculature (no-reflow) affects up to 50% of patients after unblocking a coronary artery that was causing ischaemia and acute myocardial infarction

[DOI] [PubMed] [Google Scholar] 61.Sood P.K., Nahar U., Nehru B

doi: 10.1083/jcb.202001161 78 ChangCJensenLEHurleyJH

The benefits of tirzepatide beyond weight loss include this meaningful improvement in immune-related outcomes